Pharmacological doses of melatonin reduce the glycosaminoglycan level within the infarcted heart scar

Journal of Physiology and Pharmacology

Volumn 62, Issue 1, 2011, Pages 29-35

  Drobnik, Jacek ^a   Slotwinska, D ^a   Olczak, S ^a   Tosik, D ^a   Pieniazek, A ^b   Matczak, K ^b   Koceva Chyla, A ^b   Szczepanowska, A ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

Author keywords

Cell culture; Connective tissue; Glutathione; Myocardial infarction; Myofibroblasts; Pineal gland; Rat; Reactive oxygen species

Indexed keywords

COLLAGEN; GLUTATHIONE; GLYCOSAMINOGLYCAN; INDOLEAMINE; MELATONIN; REACTIVE OXYGEN METABOLITE; SCAVENGER; THIOL DERIVATIVE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR MATRIX; HEART INFARCTION; LIPID OXIDATION; LONG TERM CARE; MALE; MORNING DOSAGE; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; RAT;

ANIMALS; CELLS, CULTURED; CICATRIX; COLLAGEN; GLUTATHIONE; GLYCOSAMINOGLYCANS; HEART; LIPID PEROXIDATION; MALE; MELATONIN; MYOCARDIAL INFARCTION; MYOFIBROBLASTS; OXIDATIVE STRESS; PINEAL GLAND; RATS; RATS, WISTAR;

EID: 79954530756     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ishihara M, Fedarko NS, Conrad HE. Involvement of phosphatidylinositol and insulin in the coordinate regulation of proteoheparan sulphate metabolism and hepatocyte growth. J Biol Chem 1987; 262: 4708-4716.
2. Jackson RL, Busch SJ, Cardin AD. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991; 7: 481-539.
3. Fomovsky GM, Thomopoulos S, Holmes JW. Contribution of extracellular matrix to the mechanical properties of the heart. J Mol Cell Cardiol 2010; 48: 490-496.
4. Braunlin EA, Berry JM, Whitley CB. Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I. Am J Cardiol 2006; 98: 416-418.
5. Thourani VH, Brar SS, Kennedy TP, et al. Nonanticoagulant heparin inhibits NF-KB activation and attenuates myocardial reperfusion injury. Am J Physiol Heart Circ Physiol 2000; 278: H2084-H2093.
6. Ventura C, Cantoni S, Bianchi F, et al. Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J Biol Chem 2007; 282: 14243-14252.
7. Judgutt BI, Joliart MJ, Khan MI. Rate of collagen deposition during healing and ventricular remodelling after myocardial infarction in rats and dog models. Circulation 1996; 94: 94-101.
8. Drobnik J, Karbownik-Lewinska M, Szczepanowska A, Slotwinska Olczak S, Jakubowski L, Dabrowski R. Regulatory influence of melatonin on collagen accumulation in the infarcted heart scar. J Pineal Res 2008; 45: 285-290.
9. Drobnik J, Ciosek J, Stempniak B, et al. Experimental hypothyroidism increases collagen and glycosaminoglycans content in the heart. J Physiol Pharmacol 2009; 60: 57-62.
10. Dahl CP, Husberg C, Gullestad L, Waehre A, Damas JK, et al. Increased production of CXCL16 in experimental and clinical heart failure: a possible role in extracellular matrix remodeling. Circ Heart Fail 2009; 2: 624-632.
11. Lakshminarayanan V, Beno DW, Costa RH, Roebuck KA. Differential regulation of interleukin-8 and intercellular adhesion molecule-1 by H2O2 and tumour necrosis factoralpha in endothelial and epithelial cells. J Biol Chem 1997; 272: 32910-32918.
12. Akgur FM, Brown MF, Zibari GB, et al. Role of superoxide in hemorrhagic shock-induced P-selectin expression. Am J Physiol Heart Circ Physiol; 2000; 279: H791-H797.
13. Kannan K, Jain SK. Oxidative stress and apoptosis. Pathophysiology 2000; 7: 153-163.
14. Lagneux C, Joyeux M, Demenge P, Ribant C, Godin-Ribout D. Protective effect of melatonin against ischemiareperfusion injury in the isolated rat heart. Life Sci 2000; 66: 503-509.
15. Drobnik J, Olczak S, Owczarek K, Hrabec Z, Hrabec E. Melatonin augments expression of the procollagen a1 (I) and a1 (III) genes, in the infarcted heart scar of pinealectomised rats. Connect Tissue Res 2010; 51: 491-496.
16. Rodriguez C, Mayo JC, Sainz RJ, at al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9.
17. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
18. Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
19. Chen Z, Chau CC, Gao J, et al. Prevention of ischemia/reperfusion induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxidase 1. J Pineal Res 2009; 46: 235-241.
20. Karbownik M, Reiter RJ. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000; 225: 9-22.
21. Reiter RJ, Manchester LC, Fuentes-Broto L, Tan DX. Cardiac hypertrophy and remodeling: pathophysiological consequences and protective actions of melatonin. J Hypertens 2010; 28(Suppl 1): S7-S12.
22. Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 2009; 15: 43-50.
23. Drobnik J, Szczepanowska A, Dabrowski R. Temporary increase of glycosaminoglycans in the heart after the left coronary artery ligation. Pathophysiology 2004; 11: 35-39.
24. Ellmam G. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
25. Aldini G, Yeum K, Russel RM, Krinski NI. A method to measure the oxidizability of both the aqueous and lipid compartments of plasma. Free Radic Biol Med 2001; 31: 1043-1050.
26. Lowry JO, Rosenbrough NJ, Randal RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
27. Woessner IF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys 1961; 93: 440-445.
28. Farndale RW, Buttle DJ, Barrot AJ. Improved quantitation and determination of sulphated glycosaminoglycans by use dimethylmethylene blue. Biochem Biophys Acta 1986; 883: 173-177.
29. Miller SC, Pandi-Perumal SR, Esquifino AI, Cardinali DP, Maestroni GJ. The role of melatonin in immunoenhancement: potential application in cancer. Int J Exp Pathol 2006; 87: 81-87.
30. Juszczak M, Drobnik J, Schwarzberg H, Guzek JW. Effect of pinealectomy and melatonin on vasopressin potentiated passive avoidance in rats. J Physiol Pharmacol 1996; 47: 621-627.
31. Ershin M, Sehirili O, Toklu S, et al. Melatonin improves cardivascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J Pineal Res 2009; 47: 97-106.
32. Goraca A, Piechota A, Huk-Kolega H. Effect of alpha-lipoic acid on LPS-induced oxidative stress in the heart. J Physiol Pharmacol 2009; 60: 61-68.
33. Goraca A, Ciejka E, Piechota A. Effects of extremly low frequency magnetic field on the parameters of oxidative stress in heart. J Physiol Pharmacol 2010; 61: 333-338.
34. Guajardo MH, Terrasa AM, Catala A. Lipid protein modifications during ascorbate Fe2+ peroxidation of photoreceptor membranes: protective effect of melatonin. J Pineal Res 2006; 41: 201-210.
35. Pablos MI, Reiter RJ, Ortiz GG, et al. Rhythms of glutatione peroxidase and glutatione reductase in brain of chick: their inhibition by light. Neurochem Int 1998; 32: 69-75.
36. Hill MF, Singal PK. Antioxidant and oxidative stress changes during heart failure subsequent to myocardial infarction in rats. Am J Pathol 1996; 148: 291-300.
37. Szarszoi O, Asemu G, Vanecek J, Ostadal B, Kolar F. Effects of melatonin on ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 2001; 5: 251-257.
38. Lee YM, Chen HR, Hsiao G, Sheu JR, Wang JJ, Yen MH. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002; 33: 72-80.